Amikacin: pharmacology, indications and cautions for use, and dose recommendations.
D000583:Amikacin / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D002490:Central Nervous System / Q000378:metabolism; D004352:Drug Resistance, Microbial; D005260:Female; D006207:Half-Life; D006801:Humans; D007408:Intestinal Absorption; D007612:Kanamycin / Q000031:analogs & derivatives*; D007700:Kinetics; D011247:Pregnancy; D014018:Tissue Distribution
D007612:Kanamycin; D000583:Amikacin